Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • CM Rawat meets Israeli...

    CM Rawat meets Israeli delegation: Uttarakhand likely to get algae, cannabis farms

    Farhat NasimWritten by Farhat Nasim Published On 2018-12-27T14:46:46+05:30  |  Updated On 27 Dec 2018 2:46 PM IST
    CM Rawat meets Israeli delegation: Uttarakhand likely to get algae, cannabis farms

    According to a press release by the government, Puremagics Ltd, an Israeli firm specialising in biotechnology, intends to produce Haematococcus pluvialis, a species of algae used in the manufacturing of cosmetics and nutritional supplements in Uttarakhand.


    New Delhi: An Israeli business delegation met Uttarakhand Chief Minister Trivendra Singh Rawat here Wednesday and discussed the setting up algae and medicinal cannabis farms in the hill state.


    According to a press release by the government, Puremagics Ltd, an Israeli firm specialising in biotechnology, intends to produce Haematococcus pluvialis, a species of algae used in the manufacturing of cosmetics and nutritional supplements in Uttarakhand.


    It further stated that the company also expressed interest in farming and processing of medicinal GMP cannabis (medical cannabis) in the state, for which it is deliberating a collaboration with Indian Industrial Hemp Association (IIHA), the only licensee of cannabis farming in Uttarakhand





    Rawat told the delegates that his government was committed to generating employment opportunities, stopping migration from the hill-state and boosting the local economy in Uttarakhand, the statement said.



    He also expressed his support and willingness in making the firm's proposal operational.


    Avi Peled, chairman of Puremagics and other executives of the firm were part of the Israeli delegation.


    Also Read: Greece eyes pot of gold as medicinal cannabis licensed
    algaeBiotechnologycannabisgmp cannabHaematococcus pluvialisiihaIndisian Industrial Hemp AssociationIsraelisraeliIsraeli firmPuremagicsPuremagics LtdTrivendra Singh RawatUttarakhanduttarakhand cm
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok